15
3SBio
1530.HK·HKEXShenyang CNFounded 19933,000 employees
Small CapbiotechPublicOncologyRare Disease
Platform: EPO Bio
Market Cap
$1.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (1530.HK)
Loading 1530.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Lisomavacamten | 153-5271 | NDA/BLA | 2 | IL-17A | CF | ||
| 153-2292 | 153-2292 | Preclinical | 1 | EZH2 | PNH |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
3SBio trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)